UMN Pharma completes $1.1 million Series B-1 financing round, with participation of 3 venture capital firms.

UMN Pharma Inc. raised $1.1 million in Series B-1 from 3 venture capitals, Pacific Rim Ventures, Nomura Research & Advisory and NIF SMBC Ventures.